Effect of Adjuvant Capecitabine or Fluorouracil, with or without Oxaliplatin, on Survival Outcomes in Stage III Colon Cancer and the Effect of Oxaliplatin on Post-Relapse Survival: A Pooled Analysis of Individual Patient Data from Four Randomised Controlled Trials

BACKGROUND: Oxaliplatin-based adjuvant therapy is the standard of care for stage III colon cancer. Adjuvant capecitabine with or without oxaliplatin versus leucovorin and fluorouracil with or without oxaliplatin has not been directly compared; therefore, we aimed to analyse the efficacy and safety o...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Lancet Oncol
Hoofdauteurs: Schmoll, Hans-Joachim, Twelves, Chris, Sun, Weijing, O'Connell, Michael J, Cartwright, Thomas, McKenna, Edward, Saif, Muhammad, Lee, Steve, Yothers, Greg, Haller, Daniel
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2014
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4435787/
https://ncbi.nlm.nih.gov/pubmed/25456367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)70486-3
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items